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Abstract
U.S. Immigration and Customs Enforcement (ICE) is responsible for detaining unauthorized aliens 
during immigration proceedings. During 2014–2015, adult ICE detainees at a California facility 
were invited to complete a survey concerning self-reported varicella history and risk factors. 
Participants underwent serological testing for varicella-zoster virus (VZV) IgG; susceptible 
individuals were offered varicella vaccination. Among 400 detainees with available serology 
results, 48 (12%) were susceptible to varicella. Self-reported varicella history was negatively 
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associated with susceptibility (adjusted odds ratio [aOR]=0.16; 95% CI=0.07, 0.35). Among 196 
detainees reporting a positive history, 95% had VZV IgG levels suggestive of varicella immunity. 
Among 44 susceptible detainees offered vaccination, 86% accepted. Given relatively high varicella 
susceptibility, targeted screening and vaccination among ICE detainees lacking a positive history 
might reduce varicella transmission risks.
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INTRODUCTION
Varicella is a highly contagious infection caused by varicella-zoster virus (VZV), with attack 
rates of 61%–100% in susceptible close contacts (Heininger & Seward, 2006). Compared 
with infections contracted during childhood, varicella infections in susceptible adults tend to 
be more severe, with greater risk for complications and hospitalizations (Marin et al., 
2008b). In tropical climates, VZV infection generally occurs at older ages relative to 
temperate climates, resulting in a greater proportion of susceptible adults (Garnett, Cox, 
Bundy, Didier, & St Catharine, 1993; Lee, 1998; Liyanage et al., 2007). In one study of adult 
immigrants in Canada, younger age, recent arrival, and originating from a tropical country 
were associated with varicella susceptibility (Greenaway et al., 2014). In the United States, 
the varicella vaccination program, initiated in 1995, has considerably reduced the incidence 
and severity of VZV infections and associated healthcare utilization (Marin, Meissner, & 
Seward, 2008a; Marin, Zhang, & Seward, 2011; Zhou, Harpaz, Jumaan, Winston, & Shefer, 
2005). Globally, routine varicella vaccination is limited to a few high-income countries 
(Bonanni et al., 2009).
U.S. Immigration and Customs Enforcement (ICE) is responsible for enforcing federal 
immigration laws, including the detention of unauthorized aliens during immigration 
proceedings. ICE admitted 440,557 aliens to detention facilities during fiscal year 2013, of 
whom 56% were Mexican nationals (Simanski, 2014). Detainees are unlikely to have 
medical or vaccination records available when brought into ICE custody. Routine varicella 
serological testing and vaccination are not included in current ICE policies for detainee 
healthcare.
Varicella outbreaks are an ongoing challenge in detention and correctional facilities (Leung 
et al., 2014; Levy et al., 2003; Public Health England, 2014; Valdarchi et al., 2008), 
including facilities that house migrants (de Valliere et al., 2011; Gétaz et al., 2010; Haas, 
Dukhan, Goldstein, Lyandres, & Gdalevich, 2014). Such outbreaks can be disruptive and 
costly, requiring isolation of cases, identification, assessment of susceptibility and cohorting 
contacts, staff furloughs, and restriction in movement, gatherings, visitations, and court 
appearances (Leung et al., 2014). Outbreaks can also spread to other facilities (Levy et al., 
2003), increasing resource expenditures to contain transmission.
We aimed to assess serological varicella susceptibility and associated risk factors among 
ICE detainees. To inform potential implementation of a varicella vaccination program, we 
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also assessed the validity of self-reported varicella history, vaccination attitudes, and 
varicella vaccine acceptance among susceptible individuals.
METHODS
Participant recruitment was conducted between August 2014 and February 2015 at a mixed-
sex California detention facility housing ICE detainees aged ≥18 years. After initial intake 
screening, ICE detainees receive a comprehensive health assessment within 14 days of 
arrival; this assessment includes a physical examination and mental health screening. In the 
absence of other clinical indications, influenza vaccine is the only routinely offered 
vaccination at the facility. Screening for other vaccine-preventable diseases is not routinely 
performed in healthy detainees.
Participants
We reviewed medical records of recently arrived detainees for participation eligibility. 
Detainees ineligible to receive varicella vaccine due to contraindications for vaccination 
(including immunocompromising conditions, any known vaccine allergies, currently taking 
immunosuppressing medications, pregnant, or acutely ill), or those with a known medical 
condition requiring chronic medications, were excluded. Detainees deemed unable by the 
attending provider to reliably consent due to mental illness or intellectual disability, or for 
whom language-specific interpretation was not readily available at the time of interview, 
were also excluded.
Trained recruitment staff supervised by senior project staff approached eligible detainees to 
explain project objectives and activities, provided a written information sheet in English or 
Spanish, and invited detainees to participate. Among detainees with limited English and/or 
Spanish language proficiency, telephonic interpreter services were used and the written 
information sheet was verbally translated unless language-specific interpretation was not 
readily available. Detainees were informed that their participation was voluntary and would 
not impact their detention, legal claims, or any legal proceedings involving ICE. For all 
detainees approached, age, sex, language, and nationality were recorded.
Data collection
We obtained a convenience sample comprised of the first 400 eligible detainees who 
consented to participate and for whom varicella serology was performed. Recruitment staff 
administered a survey to consenting participants in English, Spanish, or via telephonic 
interpreter services for other languages. The survey included questions about self-reported 
history of varicella, community of childhood household (defined as the village, town, city, 
and country where they lived during the majority of their childhood between birth and 12 
years of age), and total number of adults and minors (aged <18 years) who lived in their 
childhood household. Participants were also asked closed-ended questions regarding their 
general attitudes on vaccination and their trust of medical providers at the facility to 
recommend vaccines.
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Serological testing
Blood was drawn from participants to test for varicella IgG titer (Liaison VZV IgG assay, 
DiaSorin, Saluggia, Italy) and HIV seropositivity by enzyme-linked immunosorbent assay 
(ELISA). Varicella IgG titer values were interpreted as positive, equivocal, or negative, 
according to commercial testing laboratory reference ranges. HIV testing was performed to 
ascertain eligibility for varicella vaccination. HIV ELISA-positive samples were followed by 
a confirmatory assay. Participants were informed of their varicella and HIV serological test 
results. Participants found to be newly HIV-positive were counseled and offered additional 
testing and treatment in accordance with ICE medical policies.
Vaccination
Detainees with equivocal or negative varicella IgG serology and whom were found to be 
HIV seronegative were provided the varicella vaccine information sheet (VIS) in English, 
Spanish, or other languages as available (Centers for Disease Control and Prevention, 2008), 
informed that vaccination is voluntary, and offered the first of two vaccine doses. 
Participants who received the first dose and remained in the facility 4–8 weeks after initial 
vaccine administration were offered the second dose.
Analysis
Interview language was categorized as Spanish, English, or Other. Total childhood 
household size and number of minors were dichotomized based on the medians. Refusal to 
answer survey questions or missing responses were excluded. To assess positive and 
negative predictive value of self-reported varicella history, uncertain and negative histories 
were combined. Varicella IgG serology results were used to classify participants into 
susceptible (negative and equivocal results) and immune (positive results). Countries of 
childhood household were regionally categorized, as described elsewhere (Greenaway et al., 
2014), and grouped to ensure adequate participant numbers. To assess climate, latitude, and 
longitude estimates for the city/village of childhood household were obtained using Google 
Maps (Google, Palo Alto, CA) and grouped by climate category, according to Köppen-
Geiger classification (Greenaway et al., 2014; Kottek, Grieser, Beck, Rudolf, & Rubel, 
2006).
Statistical analyses were performed using SAS 9.3 (SAS Institute, Cary, NC) and EpiInfo 7 
(Centers for Disease Control and Prevention (CDC), Atlanta, GA). Bivariate comparisons 
were performed using Mantel-Haenszel Exact Chi-square tests assessed at α = 0.05. 
Binomial proportion confidence intervals (CIs) were calculated using the Wilson score 
method. Univariate and multivariate logistic regression modeling were utilized to test 
associations between varicella susceptibility and study variables. A backwards elimination 
approach was used for multivariate logistic regression modeling, retaining sex and age as 
potential confounders.
Human subjects
As this investigation was conducted to inform the implementation of a public health 
intervention in a defined population, it was determined to be non-research by CDC and 
therefore not subject to CDC Institutional Review Board review.
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RESULTS
We invited 671 detainees to participate, of whom 424 (63%) consented. After excluding 
detainees due to previously unidentified ineligibility or inability to obtain blood samples, 
400 participants with available serology results were included in analysis (Figure 1). No 
significant differences by age, sex, or interview language were detected between detainees 
included in the analysis and those invited but who did not participate (p > .05). Participation 
rates varied by nationality (p < .0001); detainees born in Europe and Central Asia (6, 26%) 
had significantly lower participation than those born in East and South Asia, the Pacific, 
North Africa and the Middle East (30, 60%), Latin America and the Caribbean (307, 61%), 
or Sub-Saharan Africa (57, 86%).
Participants were predominantly male (73%) with a median age of 30 years (range: 18–60 
years) (Table 1). All global regions were represented in childhood households, although 
most grew up in Latin America and the Caribbean (71%) or Sub-Saharan Africa (14%). 
More than half (56%) of participants grew up in a tropical climate. Twenty-four (6%) 
participants reported a different country of childhood household than their nationality; of 
these, 17 (71%) were born in Mexico, but reported their childhood household as being in the 
United States.
Among the 400 participants, 48 (12%; 95% CI = 9%, 16%) were susceptible to varicella, of 
whom two (4%) had equivocal serology results (Table 2). One participant was HIV-positive, 
but he was immune to varicella. Prior varicella history was reported by 196 participants, of 
whom 187 were immune (positive predictive value = 95%). Among 204 participants denying 
or unsure of varicella history, 39 were susceptible (negative predictive value = 19%).
Of the 48 susceptible detainees, 44 (91%) were still housed in the facility when serology 
results became available; of these 44, 38 (86%) consented to varicella vaccination (Figure 
1). Among the 38 receiving vaccination, eight (21%) received one dose and 30 (79%) 
received two doses before being transferred or released from the facility.
In a multivariate logistic regression model (Table 2), controlling for age and sex, childhood 
household in a tropical climate was positively associated with varicella susceptibility (aOR = 
3.04; 95% CI = 1.26, 7.33). Self-reported history of varicella was inversely associated with 
susceptibility (aOR = 0.16; 95% CI = 0.07, 0.35). No significant differences in susceptibility 
by any other variables assessed were detected in univariate or multivariate analyses (Table 
2).
More than 80% of participants agreed that vaccines can prevent diseases and are safe, and 
>90% indicated trust in facility medical staff to recommend vaccines (Table 3). Participants 
aged ≥45 years were more likely to agree that vaccines are safe, compared with those aged 
25–34 years (p = .02). No associations between vaccination attitudes and sex or global 
region of childhood household were detected (p > .05).
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DISCUSSION
We documented 12% serological susceptibility to varicella among ICE detainees at a large 
facility in California, approximately six times that of U.S. adults aged 20–49 years 
(Reynolds, Kruszon-Moran, Jumaan, Schmid, & McQuillan, 2010). Participants from 
tropical climates were more likely to be susceptible, while no significant differences by age, 
sex, interview language, household size, or global region were detected. Our report is the 
first assessing infectious disease susceptibility among ICE detainees and is useful to inform 
measures to prevent varicella infections in this population.
As a confined population, ICE detainees have increased risk of varicella exposure given 
congregate housing and frequent movement of persons (Bick, 2007; Breuer, 2004). 
Furthermore, being foreign-born adults, ICE detainees have greater likelihood of varicella 
susceptibility than the U.S.-born (Meyer, Seward, Jumaan, & Wharton, 2000), and are 
unlikely to have received childhood varicella vaccination (Bonanni et al., 2009). The 
detected level of susceptibility exceeded prior reports of 3%–6% susceptibility among adult 
migrants in Canada and U.S.-bound refugees (Greenaway et al., 2014; Leung et al., 2015), 
but was comparable to 13% susceptibility among migrant inmates at a Swiss prison where a 
varicella outbreak occurred (Gétaz et al., 2010). Given herd immunity threshold estimates of 
86%–91% to prevent varicella transmission (Plans-Rubio, 2012), and documented varicella 
outbreaks in correctional facilities where VZV seroprevalence exceeded 85% (Centers for 
Disease Control and Prevention, 1989; Gétaz et al., 2010; Valdarchi et al., 2008), our 
findings suggest that VZV transmission and outbreaks would likely occur at this facility if 
an infectious person was introduced.
More than half of participating ICE detainees originated in a tropical climate, and were more 
likely to be susceptible than detainees from temperate climates. Contributing factors to 
susceptibility in tropical climates include reduced transmission efficiency in hot, humid 
environments (Garnett et al., 1993; Lolekha et al., 2001) and being more likely to live in a 
rural setting, a proxy for low population density and frequency and closeness of interactions 
(Mandal, Mukherjee, Murphy, Mukherjee, & Naik, 1998). Since climate can be deduced 
from household location, obtaining childhood household information during intake 
procedures (in addition to self-reported varicella history) and systematizing climate 
determination might help identify potentially susceptible detainees for further testing and 
vaccination.
In our sample, more than one-third of detainees were aged ≥35 years. Compared with a prior 
study of migrants in Canada, where nearly all persons in this demographic were immune 
(Greenaway et al., 2014), 12% of detainees in this group were susceptible. Primary VZV 
infection in older age groups is associated with higher consequences in severe morbidity and 
mortality (Marin et al., 2008b). Hence, transmission of varicella within this facility could 
result in more severe cases requiring hospitalization, presenting additional challenges in 
terms of patient transport and population movement in a confined setting (Leung et al., 
2014).
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Vaccination programs reduce the risk of disease transmission within correctional facilities 
and in the wider community following release (Sequera, Garcia-Basteiro, & Bayas, 2013). 
Strategies to prevent varicella transmission in adults include: (i) post-exposure vaccination; 
(ii) routine vaccination; and (iii) routine or targeted serological testing with subsequent 
vaccination of susceptible individuals. Post-exposure vaccination can considerably reduce 
varicella infections and hospitalizations (Souty et al., 2015), but timely implementation of 
response measures and identification of exposed detainees and staff can be challenging 
(Leung et al., 2014). Routine varicella vaccination increases coverage at elevated cost, given 
unnecessary vaccine administration among immune individuals. In one migrant detention 
facility in Switzerland, general vaccination was more effective than targeted testing in 
preventing varicella outbreaks, but incurred more than double the costs (de Valliere et al., 
2011). Serological testing and subsequent vaccination can provide a more cost-effective 
approach for varicella prevention, including for recent migrants (Merrett, Schwartzman, 
Rivest, & Greenaway, 2007; Smith & Roberts, 2000). However, the transient nature of ICE 
detainees presents challenges in obtaining test results and administering vaccine prior to 
release.
Self-reported varicella history offers a rapid approach to identify potentially susceptible 
individuals. Among ICE detainees, a positive self-reported history of varicella was generally 
reliable; our calculated positive predictive value (95%) exceeded prior estimates based on 
migrant prisoners in Switzerland (Gétaz et al., 2010) and refugees in the United States 
(Christiansen & Barnett, 2004). However, a negative history was not accurate; fewer than 
20% of participants who denied history or were unsure were susceptible. Hence, detainees 
denying or unsure of their history might be targeted for serological testing. Among 
immunocompromised, pregnant, or other high-risk detainees, serological testing might be 
performed regardless of varicella history. For the general population in the United States, the 
Advisory Committee on Immunization Practices recommends a healthcare provider’s 
documentation or verification of a history of varicella or herpes zoster as evidence of 
immunity, since this is a more specific definition than self-reported history and minimizes 
the possibility of false-positive results (Marin, Guris, Chaves, Schmid, & Seward, 2007). 
However, given lack of access to historical medical records and potential challenges among 
ICE detainees of accurately describing the disease presentation, the feasibility of 
implementing this definition in this population is low.
Barriers to varicella vaccination implementation in facilities housing ICE detainees include 
the requirement to administer two doses; a single dose of varicella vaccine does not provide 
sufficient population immunity to prevent transmission, especially in high-contact settings 
(Marin et al., 2008a), and the minimum interval between the doses is 4–8 weeks (Marin et 
al., 2007). Frequent movement among ICE detainees can interfere with medical follow-up 
(Schneider & Lobato, 2007). In the present study, more than one-fifth of susceptible 
detainees who received one dose of varicella vaccine were transferred or released before the 
second dose could be administered. Susceptible detainees were advised to seek medical 
consultation to receive a second dose if released before series completion. However, vaccine 
access may be limited if the detainee is removed from the United States, or if they are 
uninsured or without financial means after release. Distrust of facility and medical staff is 
another potential challenge to vaccination implementation. Although ICE detainees 
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generally reported positive attitudes toward vaccination and trust for medical providers, 14% 
of susceptible detainees declined to receive varicella vaccination, comparable to refusal rates 
in an immigrant detention facility in Israel (15.6%) (Haas et al., 2014). As detainees who 
agreed to participate might have greater trust concerning vaccination and medical providers, 
the refusal rate among all ICE detainees might exceed that observed.
This study has several limitations. We obtained a convenience sample of detainees from one 
facility. The top four countries represented (Mexico, El Salvador, Guatemala, and Honduras) 
were consistent with broader ICE population demographics (Simanski, 2014). However, 
overrepresentation of participants from Latin America and the Caribbean might have 
obscured susceptibility comparisons by global region. Low participation rates among 
European and Central Asian detainees were observed, although these represented a minority 
of individuals approached. Attitude and provider trust assessments among participants might 
overestimate those of the wider detainee population. Given the migration history of ICE 
detainees, childhood household was used in lieu of nationality when assessing varicella 
susceptibility. Only 6% of detainees had a different country of birth than their childhood 
household. However, as the age of probable VZV exposure can vary between climates, 
childhood household might not be the primary exposure site for all detainees. We did not ask 
participants about their vaccination history, given their nationalities and limited global 
implementation of varicella vaccination (Bonanni et al., 2009), although a few spent their 
childhood in high-income countries where varicella vaccine is routinely administered. We 
did not assess population density in community of childhood household; reliable population 
size and geographic area estimates for communities represented in the sample were 
unavailable. Variability in the specificity of participants’ village/town/city of childhood 
household may have reduced overall geocoding accuracy for climate assessments. We also 
did not ask about participant occupation or contact with children, which may be relevant to 
VZV exposure. Finally, given their detention status, participants may have provided 
inaccurate interview responses due to perceived benefit. However, no participation 
incentives were provided, and project staff emphasized that participation would have no 
impact on their detention or legal proceedings.
CONCLUSION
Our study represents the first assessment of a preventive health initiative in an ICE detention 
facility. We detected 12% varicella susceptibility among adult ICE detainees and 95% 
positive predictive value of a reported history of varicella. Given the high level of population 
susceptibility, targeted screening and vaccination among detainees who deny or are unsure 
of their varicella history, had a childhood household in a tropical climate, or are at elevated 
risk for complications from varicella might be considered. While this approach does not 
eliminate the possibility of VZV transmission, it could provide an effective strategy for 
minimizing disruptions caused by VZV exposures in ICE facilities.
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Figure 1. 
Participant recruitment, serological testing, and vaccination among U.S. Immigration and 
Customs Enforcement detainees at a California detention facility.
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Table 1
Demographic characteristics among participating detainees (N = 400).
Characteristic Value
Age (years), median (range) 30 (18–60)
Sex, n (%)
 Female 102 (25.5)
 Male 298 (74.5)
Interview language, n (%)
 English 105 (26.3)
 Spanish 254 (63.5)
 Other 41 (10.3)
Total number of persons in childhood household, median (range)a,b 7 (2–48)
Number of minors aged <18 years in childhood household, median (range)a,c 4 (1–25)
Nationality, n (%)d
 Mexico 215 (53.8)
 El Salvador 33 (8.3)
 Guatemala 28 (7.0)
 Honduras 20 (5.0)
 Ghana 15 (3.8)
 Other 89 (22.3)
Global region of childhood household, n (%)e
 Latin America and the Caribbean 285 (71.3)
 Sub-Saharan Africa 57 (14.3)
 U.S. and Western Europe 24 (6.0)
 South Asia 19 (4.8)
 North Africa and the Middle East 6 (1.5)
 East Asia and the Pacific 5 (1.3)
 Eastern Europe and Central Asia 4 (1.0)
Footnotes: Rounded figures might not add to 100%.
a
Refers to self-reported number of persons (adults and/or minors) living in household during majority of childhood between birth and 12 years old.
b
Responses were missing for two participants.
c
Responses were missing for four participants.
d
Refers to country of citizenship based on U.S. Immigration and Customs Enforcement records.
e
Based on country where detainee spent majority of childhood between birth and 12 years old.
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Table 2
Serological varicella susceptibility and logistic regression modeling in relation to demographic and geographic 
factors among participating detainees.
Variable Totaln (%) Susceptible to varicella% 
(95% CI)
UnivariateOR (95% CI) MultivariateaOR (95% CI)
Overall 400 (100) 12.0 (9.2, 15.6)
Sex
 Female 102 (25.5) 13.7 (8.4, 21.7) 1.24 (0.63, 2.41) 1.52 (0.73, 3.14)
 Male 298 (74.5) 11.4 (8.3, 15.5) Ref Ref
Age (years)
 <25 107 (26.8) 10.3 (5.8, 17.5) 0.80 (0.26, 2.47) 0.60 (0.18, 1.99)
 25–34 156 (39.0) 12.8 (8.5, 19.0) 1.03 (0.36, 2.94) 0.74 (0.24, 2.28)
 35–44 97 (24.3) 12.4 (7.2, 20.4) 0.99 (0.32, 3.01) 0.71 (0.22, 2.29)
 ≥45 40 (10.0) 12.5 (5.5, 26.1) Ref Ref
Interview language
 English 105 (26.3) 7.6 (3.9, 14.3) Ref -
 Spanish 254 (63.5) 13.4 (9.7, 18.1) 1.87 (0.84, 4.20)
 Other 41 (10.3) 14.6 (6.9, 28.4) 2.08 (0.67, 6.41)
Self-reported history of varicella
 Yes 196 (49.0) 4.6 (2.4, 8.5) 0.19 (0.09, 0.40) 0.16 (0.07, 0.35)
 No 160 (40.0) 20.6 (15.1, 27.6) Ref Ref
 Not sure 44 (11.0) 13.6 (6.4, 26.7) 0.61 (0.24, 1.56) 0.64 (0.24, 1.68)
Total number of persons living in childhood householda
 ≤7 238 (59.8) 13.0 (9.3, 17.9) 1.35 (0.71, 2.56) -
 >7 160 (40.2) 10.0 (6.3, 15.6) Ref
Number of minors aged <18 years in childhood householda
 ≤4 229 (57.8) 14.0 (10.1, 19.1) 1.78 (0.92, 3.44)
 >4 167 (42.2) 8.4 (5.1, 13.6) Ref -
Climate in community of childhood householdb
 Arid/cold/polar 66 (16.6) 12.1 (6.3, 22.1) 2.05 (0.71, 5.94) 2.22 (0.74, 6.63)
 Temperate 111 (27.9) 6.3 (3.1, 12.5) Ref Ref
 Tropical 221 (55.5) 14.9 (10.8, 20.2) 2.61 (1.11, 6.10) 3.04 (1.26, 7.33)
Global region of childhood householdc
 Latin America and the Caribbean 285 (71.3) 13.0 (9.6, 17.4) Ref -
 Sub-Saharan Africa 57 (14.3) 8.8 (3.8, 19.0) 0.64 (0.24, 1.72)
 U.S./W. Europe/E. Europe & 
Central Asia
28 (7.0) 3.6 (0.6, 17.7) 0.25 (0.03, 1.87)
 S. & E. Asia/Pacific/N. Africa & 
Middle East
30 (7.5) 16.7 (7.3, 33.6) 1.34 (0.48, 3.72)
Footnotes: Rounded figures might not add to 100%. Boldface values indicate statistical significance (p < .05). Abbreviations: CI = confidence 
interval; OR = odds ratio; aOR = adjusted odds ratio.
a
Refers to self-reported number of persons (adults and/or minors) living in household during majority of childhood between birth and 12 years old.
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b
Based on the village/town/city where detainee spent majority of childhood between birth and 12 years old.
c
Based on the country where detainee spent majority of childhood between birth and 12 years old.
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